The Natural Cytotoxicity Receptor NKp46 is Dispensable for IL-22-mediated Innate Intestinal Immune Defense Against Citrobacter Rodentium
Overview
Authors
Affiliations
Natural cytotoxicity receptors (including NKp30, NKp44, and NKp46 in humans and NKp46 in mice) are type I transmembrane proteins that signal NK cell activation via ITAM-containing adapter proteins in response to stress- and pathogen-induced ligands. Although murine NKp46 expression (encoded by Ncr1) was thought to be predominantly restricted to NK cells, the identification of distinct intestinal NKp46(+) cell subsets that express the transcription factor Rorc and produce IL-22 suggests a broader function for NKp46 that could involve intestinal homeostasis and immune defense. Using mice carrying a GFP-modified Ncr1 allele, we found normal numbers of gut CD3(-)GFP(+) cells with a similar cell surface phenotype and subset distribution in the absence of Ncr1. Splenic and intestinal CD3(-)NKp46(+) cell subsets showed distinct patterns of cytokine secretion (IFN-gamma, IL-22) following activation via NK1.1, NKp46, IL-12 plus IL-18, or IL-23. However, IL-22 production was sharply restricted to intestinal CD3(-)GFP(+) cells with the CD127(+)NK1.1(-) phenotype and could be induced in an Ncr1-independent fashion. Because NKp46 ligands can trigger immune activation in the context of infectious pathogens, we assessed the response of wild-type and Ncr-1-deficient Rag2(-/-) mice to the enteric pathogen Citrobacter rodentium. No differences in the survival or clinical score were observed in C. rodentium-infected Rag2(-/-) mice lacking Ncr1, indicating that NKp46 plays a redundant role in the differentiation of intestinal IL-22(+) cells that mediate innate defense against this pathogen. Our results provide further evidence for functional heterogeneity in intestinal NKp46(+) cells that contrast with splenic NK cells.
Zang J, Mei Y, Zhu S, Yin S, Feng N, Ci T Pharmaceutics. 2024; 16(7).
PMID: 39065636 PMC: 11279587. DOI: 10.3390/pharmaceutics16070939.
Huang C, Zhu W, Li Q, Lei Y, Chen X, Liu S Nat Commun. 2024; 15(1):5981.
PMID: 39013884 PMC: 11252441. DOI: 10.1038/s41467-024-50266-4.
Nathalie G, Bonamichi B, Kim J, Jeong J, Kang H, Hartland E Mol Cells. 2024; 47(3):100007.
PMID: 38238205 PMC: 11004397. DOI: 10.1016/j.mocell.2023.100007.
Jo H, Lee D, Go C, Jang Y, Chu N, Bae S Int J Mol Sci. 2022; 23(18).
PMID: 36142515 PMC: 9505994. DOI: 10.3390/ijms231810612.
Activation and Suppression of Group 3 Innate Lymphoid Cells in the Gut.
Zhou W, Sonnenberg G Trends Immunol. 2020; 41(8):721-733.
PMID: 32646594 PMC: 7395873. DOI: 10.1016/j.it.2020.06.009.